profit from every $100 of sales.
$0$100
ASP Isotopes
$2.14+3.13% today
-75.9% in 1 year
1-year low $1.721-year high $8.87
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What ASP Isotopes sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $23.8 million in 2025, with -$175 million of profit last year.
SalesProfit
ASP Isotopes vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| ASP Isotopes | No profit yet | ||
 Shin-Etsu Chemical | 18.5× · Fair price | ||
 BASF | 29.4× · Fair price | ||
 Saudi Basic Industries | No profit yet | ||
 Dow | No profit yet |
AI analysis
An AI analyst reads ASP Isotopes's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 4 | 24 | |
| 0 | 0 | 2 | 3 | |
| -5 | -16 | -26 | -57 | |
| -5 | -16 | -32 | -157 | |
| -5 | -16 | -32 | -175 | |
| -0.18 | -0.49 | -0.63 | -2.11 | |
| – | 32.1% | 38.6% | 14.3% | |
| – | -3,704.6% | -636.0% | -239.8% | |
| – | -3,761.0% | -780.3% | -734.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 12 | 28 | 94 | 498 |
| Cash | 2 | 8 | 62 | 286 |
| Total debt | 1 | 2 | 38 | 216 |
| Total liabilities | 3 | 9 | 43 | 235 |
| 10 | 16 | 48 | 204 | |
| 27 | 33 | 56 | 83 | |
| -36.7% | -69.3% | -29.6% | -29.9% | |
| -50.4% | -99.9% | -67.5% | -85.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -3 | -5 | -17 | -38 | |
| 4 | 2 | 11 | 10 | |
| -7 | -8 | -28 | -47 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 2 | 9 | 9 | 16 |
Valuation
- –
- –
- –
- 2.8×
- 13.8×
- –
- –
- -14.5%
- -53.4%
- 0.0%
Profitability
- 14.3%
- -239.8%
- -734.2%
- -633.6%
- -13.0%
- -50.4%
- -117.2%
- -29.5%
- -14.3%
- 59.8%
Growth
- +642.1%
- –
- −69.0%
- –
- +24.7%
Financial health
- -0.4×
- 0.91
- 44.6%
- 59.7×
- 4.39
- 4.37
- 0.05
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 4%of 988
Bottom 5%of 987
What analysts expect
- Average price target
- $13.00
- Range
- $13.00 – $13.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 10, 2026 | -0.84 | -0.14 | −514.6% |
| Nov 19, 2025 | -0.15 | -0.15 | +0.0% |
| Aug 14, 2025 | -1.03 | -1.03 | +0.0% |
| May 20, 2025 | -0.12 | -0.12 | +0.0% |
| Mar 31, 2025 | -0.13 | -0.09 | −44.4% |
| Nov 19, 2024 | -0.12 | -0.09 | −33.3% |
| Aug 19, 2024 | -0.24 | – | – |
| May 15, 2024 | -0.16 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
24No pass
Benjamin Graham
37No pass
Philip Fisher
28No pass
Peter Lynch
–Not enough data
Joel Greenblatt
0No pass
Charlie Munger
18No pass
Terry Smith
16No pass
Questions about ASP Isotopes
Is ASP Isotopes a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the ASP Isotopes AI analysis
What does ASP Isotopes do?
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. It is in Chemicals.
Does ASP Isotopes pay a dividend?
No. ASP Isotopes does not pay a dividend at the moment.
Is ASP Isotopes stock halal?
No. ASP Isotopes does not pass our halal screen: its debt is 66% of its market value, at or above the 33% limit. How we check
How has ASP Isotopes stock done over the past year?
Down 75.9% over the past twelve months, to $2.14. It traded between $1.72 and $8.87 and is 75.9% below its high.
Who are ASP Isotopes's competitors?
The largest listed companies in the same industry are Shin-Etsu Chemical, BASF, Saudi Basic Industries and Dow. The peers table on this page compares their profit, growth and price with ASP Isotopes's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.